Global Mucopolysaccharidosis Treatment Market to Witness Robust Growth, Projected to Reach USD 5,014.5 Million by 2035 Growing at a CAGR of 5.9% | FMI
Rising health awareness, increasing prevalence of various forms of mucopolysaccharidosis worldwide, continuous advances in ...
Hosted on MSN3d
RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded Use
Ultragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...
BBC16d
Christmas joy for boy after stem cell transplant
In 2021, Gunner from Highley, Shropshire, was diagnosed with Mucopolysaccharidosis Type I Hurler Syndrome, which stops his body breaking down sugar. He was given one-to-two years to live without a ...